Jim Cramer Expresses Bullish View on Two Stocks Highlights Potential Upside for One
Arkade Developers Reports Q4 Loss of Rs 10945 Crore Despite Revenue Growth
Malaysian Food Startup Aims to Commercialize LabGrown Unagi
Prairie Operating PROP Faces NearTerm Headwinds But LongTerm Bull Case Remains Intact
Vestas Wind Systems Shares Decline After Company Flags Margins at Low End of Forecast Range
Borosil Glass Works Surges Over 200 in a Year on Strong Operational Performance
Beeline Holdings Inc BLNE Q1 2026 Earnings Significant EPS Miss Sends Stock Lower
VTVT Q1 2026 Earnings Massive EPS Beat Driven by OneTime Items Stock Declines
Park Aerospace Q1 2026 Earnings EPS of 015 Drives Stock Rally Amid Steady Operational Execution
CLST Q3 2025 Earnings Catalyst Bancorp Posts 013 EPS Stock Inches Higher
INMD Q1 2026 Earnings EPS Misses Estimates Stock Rises on Potential Optimism
NSP Q1 2026 Earnings EPS Surpasses Estimates as Stock Rises
Aduro Clean Technologies ADUR Shows Modest Uptick as Stock Consolidates Near Support
Editas Medicine Surges 1591 Gene Editing Stock Breaks Above Key Support
Kayne Anderson BDC Inc KBDC Holds Steady as Slight Decline Points to Consolidation Near Key Levels
BioRad Laboratories BIO Gains 2 as Shares Approach Key Resistance Level
PennantPark Floating Rate Capital PFLT Posts 116 Gain as Stock Approaches Key Resistance
Bitcoin Slips Below 73000 Mark CryptoRelated Equities Follow Suit
Amplitech Group Inc AMPG Q1 2026 Earnings EPS Misses Estimates as Stock Declines
Boyd Group Services BGSI Edges Higher as Stock Consolidates Near Support
CDNL Q1 2026 Earnings EPS Surges Past Estimates Revenue Details Absent Stock Slides
MNKD Q1 2026 Earnings Significant EPS Miss Overshadowed by Stock Rally
Johnson Controls Q1 2026 Earnings EPS Surpasses Estimates Shares Rise
SuRo Capital Corp 600 Notes due 2026 SSSSL Q1 2026 Earnings Massive EPS Surprise Driven by Investment Gains
PHR Q1 2026 Earnings EPS Surges Past Estimates with 32373 Beat Stock Climbs 35
VCEL Q1 2026 Earnings EPS Surprise of 241 Fails to Lift Shares
Traws Pharma Q1 2026 Earnings Narrower Than Expected Loss Despite No Revenue